RDUS - Radius Health, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/8/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
652.22M600.83M930.83M1.19B1.12B
Enterprise Value 3
731.37M642.30M960.69M1.19B1.11B
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
3.393.456.088.859.69
Price/Book (mrq)
N/AN/AN/AN/A40.12
Enterprise Value/Revenue 3
3.8213.4017.2625.5327.05
Enterprise Value/EBITDA 6
-7.25-20.89-53.65-51.18-38.47

Trading Information

Stock Price History

Beta (5Y Monthly) 1.19
52-Week Change 3-40.23%
S&P500 52-Week Change 34.59%
52 Week High 329.97
52 Week Low 310.32
50-Day Moving Average 313.36
200-Day Moving Average 315.92

Share Statistics

Avg Vol (3 month) 3608.63k
Avg Vol (10 day) 3565.07k
Shares Outstanding 546.39M
Float 46.28M
% Held by Insiders 10.37%
% Held by Institutions 1112.67%
Shares Short (Jun 14, 2020) 46.74M
Short Ratio (Jun 14, 2020) 412.85
Short % of Float (Jun 14, 2020) 420.08%
Short % of Shares Outstanding (Jun 14, 2020) 414.54%
Shares Short (prior month May 14, 2020) 45.97M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Apr 23, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin -66.82%
Operating Margin (ttm)-55.37%

Management Effectiveness

Return on Assets (ttm)-28.40%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)191.4M
Revenue Per Share (ttm)4.14
Quarterly Revenue Growth (yoy)60.60%
Gross Profit (ttm)158.03M
EBITDA -103.81M
Net Income Avi to Common (ttm)-127.89M
Diluted EPS (ttm)-2.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.98M
Total Cash Per Share (mrq)2.97
Total Debt (mrq)217.13M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.05
Book Value Per Share (mrq)-1.60

Cash Flow Statement

Operating Cash Flow (ttm)-81.14M
Levered Free Cash Flow (ttm)-33.14M